Completed OBSERVATIONAL NCT04502940

Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?

Can we Measure Pancreatitis Severity With Flow Cytometry?

Sponsor: Istanbul Training and Research Hospital

Conditions Immune System Diseases Lymphocytic Infiltrate Pancreatitis

Updated 7 times since 2020 Last updated: Apr 30, 2021 Started: Jun 1, 2020 Primary completion: Apr 1, 2021 Completion: Apr 29, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Immune System Diseases and Lymphocytic Infiltrate and is currently completed. Istanbul Training and Research Hospital leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Jun 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — Mar 2021 [monthly]

Recruiting
Sep 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istanbul Training and Research Hospital

Data source: Istanbul Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)